Reuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz
Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working?
Barbara believes AI will be crucial in segmenting audiences and stakeholders for enhancing tailored interactions and enabling real-time personalized patient experience.
Image Source: Canva
About the Author:
Barbara Albientz
Barbara is an accomplished leader with robust experience in the pharmaceutical and biotechnology industries, specializing in strategic leadership across research, development, and commercialization.
Related Post: Reuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer
Himanshu brings over 12 years of Pharma, Life Sciences, and Biotech expertise to Pharmashots. A self-proclaimed "Pharma Geek," his passion for the industry shines through. His career path blends hands-on lab research with high-level consulting at firms like PwC-Health Industries and Novartis. Himanshu holds a degree in Immunology from the University of Leeds, and boasts further credentials from IIM Lucknow and the London School of Economics. Connect with Himanshu to dive deeper into the dynamic world of pharmaceuticals and life sciences.
